Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion type Assertion NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_head.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion description "[Accordingly, beneficial pleiotropic effects of statins on coronary artery disease may be attributable, in part, to attenuation of overexpression of PAI-1 mediated by the 3'-UTR in syndromes of insulin resistance (such as the metabolic syndrome) and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_provenance.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion evidence source_evidence_literature NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_provenance.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion SIO_000772 20299979 NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_provenance.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion wasDerivedFrom befree-20150227 NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_provenance.
- NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_assertion wasGeneratedBy ECO_0000203 NP1006455.RAFOkUFWt0_oYQP9I0TCRwiZSxYSJf4l6h5gfbULHh_p8130_provenance.